Search research articles
Contact Us
Filters
Showing results (151-160 of 160) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 160 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2000
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer
T De Pas, F de Braud, R Danesi, et al.
The Pharmacogenomics Journal
|
March 5, 2014
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia
A Di Paolo, M Polillo, M Capecchi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 2, 2018
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
R Minari, P Bordi, M Del Re, et al.
ESMO Open
|
May 13, 2021
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
N Silvestris, A Argentiero, A Natalicchio, et al.
ESMO Open
|
May 21, 2021
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
M Gallo, V Adinolfi, L Morviducci, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
February 29, 2012
Atopic dermatitis (AD) management in an Italian pediatric clinic
G Ruggiero, C Gelmetti, M C Adamo, et al.
ESMO Open
|
June 6, 2021
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies
A Russo, L Incorvaia, M Del Re, et al.
ESMO Open
|
June 1, 2023
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, M Montagnani, M Gallo, et al.
ESMO Open
|
December 9, 2023
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
N Silvestris, T Franchina, M Gallo, et al.
ESMO Open
|
July 1, 2022
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
W Bruno, B Dalmasso, M Barile, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 160) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 160 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2000
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer
T De Pas, F de Braud, R Danesi, et al.
The Pharmacogenomics Journal
|
March 5, 2014
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia
A Di Paolo, M Polillo, M Capecchi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 2, 2018
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
R Minari, P Bordi, M Del Re, et al.
ESMO Open
|
May 13, 2021
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
N Silvestris, A Argentiero, A Natalicchio, et al.
ESMO Open
|
May 21, 2021
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
M Gallo, V Adinolfi, L Morviducci, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
February 29, 2012
Atopic dermatitis (AD) management in an Italian pediatric clinic
G Ruggiero, C Gelmetti, M C Adamo, et al.
ESMO Open
|
June 6, 2021
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies
A Russo, L Incorvaia, M Del Re, et al.
ESMO Open
|
June 1, 2023
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, M Montagnani, M Gallo, et al.
ESMO Open
|
December 9, 2023
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
N Silvestris, T Franchina, M Gallo, et al.
ESMO Open
|
July 1, 2022
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
W Bruno, B Dalmasso, M Barile, et al.
Page
of 16